CountryOfPapers CountryOfPapers
Journal list Promote
verified COP 22,9 · D1 • database Scopus / SJR & Web of Science indexed
Drug Resistance Updates
Bi Monthly
United Kingdom · Churchill Livingstone
workspace_premium D1 Top 10% — Pharmacology lock_open Open Access

Drug Resistance Updates

Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance. It covers both basic research and clinical...

ISSN: 1368-7646
Publisher: Churchill Livingstone
Category: Infectious Diseases
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
COP Index trending_up
22,9 D1 Top 10%

1 of 284 journals in Pharmacology

H-index · SJR 139 · 5,282
Acceptance rate pie_chart
23% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
3.072 € Open Access
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

COP Index

22,9

D1 Top 10%

SJR Impact

5,282

H-index

139

Docs (year)

102

Docs 3y

123

Total refs

9024

Cites 3y

2883

Citable 3y

121

Cites/Doc 2y

21.83

Ref/Doc

88.47

Immediate OA

3072 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Liposomal formulations of anticancer drugs: selectivity and effectiveness

View more

Workshop on ABC Transporters and Human Diseases

View more

Vascular remodeling and clinical resistance to antiangiogenic cancer therapy

View more

The role of impaired transport in (pre)clinical resistance to methotrexate: insights on new antifolates

View more

The pH difference between tumor and normal tissue offers a tumor specific target for the treatment of cancer

View more

The apicoplast as an antimalarial drug target

View more

The 90th Annual Meeting of the American Association for Cancer Research (AACR) Philadelphia, USA, 10-14 April 1999

View more

The TRAIL to an anti-cancer agent

View more

p53 as a therapeutic target: unresolved issues on the road to cancer therapy targeting mutant p53

View more

New developments: Chloroquine-resistance in Plasmodium falciparum

View more

Multiple resistance mechanisms to azole antifungals in yeast clinical isolates

View more

Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use

View more
SHOW MORE ARTICLES

Phenotypic antibiotic tolerance of Staphylococcus aureus in implant-related infections: relationship with in vitro colonization of artificial surfaces

View more

Leishmaniasis: drugs in the clinic, resistance and new developments

View more

Invasive Candida infections in the neonate

View more

Infectious disease 2000: drug resistance and new drugs

View more

Immunotherapy for invasive fungal infections: from bench to bedside

View more

Hypoxic cytotoxic agents: a new approach to cancer chemotherapy

View more

Future perspectives for the development of P-glycoprotein modulators

View more

Erratum to "Strategies to target HER2/neu overexpression for cancer therapy"

View more

Erratum

View more

Effects of HER-2/neu on chemosensitivity of tumor cells

View more

EDITORIAL

View more

EDITORIAL

View more

FAQs